Use of synthetic adrenocorticotropic hormone in patients with IgA nephropathy

Use of synthetic adrenocorticotropic hormone in patients with IgA nephropathy

Abstract Background Synthetic adrenocorticotropic hormone (ACTH) has been demonstrated to be effective in patients with membranous nephropathy, minimal change disease and some histological subtypes of focal segmental glomerulosclerosis. Its clinical impact in patients with IgA nephropathy is current...

Full description

Bibliographic Details
Main Authors: Bhanu Prasad, Shelley Giebel, Michelle C. E. McCarron, Nelson Leung
Format: Article
Language:English
Published: BMC 2018-05-01
Series:BMC Nephrology
Subjects:
IgA nephropathy
Adrenocorticotropic hormone
Proteinuria
Prednisone
Online Access:http://link.springer.com/article/10.1186/s12882-018-0915-4

Internet

http://link.springer.com/article/10.1186/s12882-018-0915-4

Similar Items